Gerardo Priotto

Summary

Publications

  1. pmc Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study
    Gerardo Priotto
    Epicentre, 75011 Paris, France
    BMJ 336:705-8. 2008
  2. ncbi request reprint Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo
    Gerardo Priotto
    Epicentre, Paris, France
    Clin Infect Dis 45:1435-42. 2007
  3. ncbi request reprint Artesunate and sulfadoxine-pyrimethamine combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Uganda: a randomized, double-blind, placebo-controlled trial
    Gerardo Priotto
    Epicentre, 8 rue Saint Sabin, 75011 Paris, France
    Trans R Soc Trop Med Hyg 97:325-30. 2003
  4. doi request reprint Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial
    Gerardo Priotto
    Epicentre, Paris, France
    Lancet 374:56-64. 2009
  5. pmc Nifurtimox plus Eflornithine for late-stage sleeping sickness in Uganda: a case series
    Francesco Checchi
    Epicentre, Paris, France
    PLoS Negl Trop Dis 1:e64. 2007
  6. ncbi request reprint Antimalarial efficacy of sulfadoxine-pyrimethamine, amodiaquine and a combination of chloroquine plus sulfadoxine-pyrimethamine in Bundi Bugyo, western Uganda
    Francesco Checchi
    Epicentre, Paris, France
    Trop Med Int Health 9:445-50. 2004
  7. pmc Early prediction of treatment efficacy in second-stage gambiense human African trypanosomiasis
    Gerardo Priotto
    Epicentre, Paris, France
    PLoS Negl Trop Dis 6:e1662. 2012
  8. ncbi request reprint Molecular genotyping in a malaria treatment trial in Uganda - unexpected high rate of new infections within 2 weeks after treatment
    Kefas Mugittu
    Ifakara Health Research and Development Centre, Ifakara, Tanzania
    Trop Med Int Health 12:219-23. 2007
  9. pmc Malaria epidemics and interventions, Kenya, Burundi, southern Sudan, and Ethiopia, 1999-2004
    Francesco Checchi
    Department of Infectious and Tropical Disease, London School of Hygiene and Tropical Medicine, London, United Kingdom
    Emerg Infect Dis 12:1477-85. 2006
  10. ncbi request reprint The outbreak and control of Ebola viral haemorrhagic fever in a Ugandan medical school
    Medard Bitekyerezo
    Mbarara University Teaching Hospital, Uganda
    Trop Doct 32:10-5. 2002

Collaborators

Detail Information

Publications10

  1. pmc Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study
    Gerardo Priotto
    Epicentre, 75011 Paris, France
    BMJ 336:705-8. 2008
    ..To assess the safety and effectiveness of eflornithine as first line treatment for human African trypanosomiasis...
  2. ncbi request reprint Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo
    Gerardo Priotto
    Epicentre, Paris, France
    Clin Infect Dis 45:1435-42. 2007
    ..We compared the efficacy and safety of the nifurtimox-eflornithine drug combination with the standard eflornithine regimen for the treatment of second-stage disease...
  3. ncbi request reprint Artesunate and sulfadoxine-pyrimethamine combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Uganda: a randomized, double-blind, placebo-controlled trial
    Gerardo Priotto
    Epicentre, 8 rue Saint Sabin, 75011 Paris, France
    Trans R Soc Trop Med Hyg 97:325-30. 2003
    ..Treatment efficacy improved with SPAS3 but the cure rate at day 28 was modest. The combinations were well tolerated and safe. In areas where SP resistance is prevalent other combinations should be considered...
  4. doi request reprint Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial
    Gerardo Priotto
    Epicentre, Paris, France
    Lancet 374:56-64. 2009
    ..We assessed the efficacy and safety of nifurtimox-eflornithine combination therapy (NECT) for second-stage disease compared with the standard eflornithine regimen...
  5. pmc Nifurtimox plus Eflornithine for late-stage sleeping sickness in Uganda: a case series
    Francesco Checchi
    Epicentre, Paris, France
    PLoS Negl Trop Dis 1:e64. 2007
    ....
  6. ncbi request reprint Antimalarial efficacy of sulfadoxine-pyrimethamine, amodiaquine and a combination of chloroquine plus sulfadoxine-pyrimethamine in Bundi Bugyo, western Uganda
    Francesco Checchi
    Epicentre, Paris, France
    Trop Med Int Health 9:445-50. 2004
    ..Our study also confirms previous findings that resistance is considerably underestimated by 14-day follow-ups. Antimalarial policy decisions should therefore be based on 28-day studies, with PCR adjustment to distinguish re-infections...
  7. pmc Early prediction of treatment efficacy in second-stage gambiense human African trypanosomiasis
    Gerardo Priotto
    Epicentre, Paris, France
    PLoS Negl Trop Dis 6:e1662. 2012
    ..We analyzed individual patient data from 12 programs conducted by Médecins Sans Frontières in Uganda, Sudan, Angola, Central African Republic, Republic of Congo and Democratic Republic of Congo searching for early efficacy indicators...
  8. ncbi request reprint Molecular genotyping in a malaria treatment trial in Uganda - unexpected high rate of new infections within 2 weeks after treatment
    Kefas Mugittu
    Ifakara Health Research and Development Centre, Ifakara, Tanzania
    Trop Med Int Health 12:219-23. 2007
    ..2%)] and 14 [24/51 (47.1%)]. These results impact significantly on resistance monitoring and point to the value of genotyping all recurrent infections in antimalarial trials...
  9. pmc Malaria epidemics and interventions, Kenya, Burundi, southern Sudan, and Ethiopia, 1999-2004
    Francesco Checchi
    Department of Infectious and Tropical Disease, London School of Hygiene and Tropical Medicine, London, United Kingdom
    Emerg Infect Dis 12:1477-85. 2006
    ....
  10. ncbi request reprint The outbreak and control of Ebola viral haemorrhagic fever in a Ugandan medical school
    Medard Bitekyerezo
    Mbarara University Teaching Hospital, Uganda
    Trop Doct 32:10-5. 2002
    ..The implications for similar institutions in East Africa are discussed...